公开(公告)号：US5294629A

公开(公告)日：1994-03-15

申请号：US037671

申请日：1993-03-25

申请人： Tomoya Machinami ,  Kazue Yasufuku ,  Seiji Shibahara ,  Fumiya Hirano ,  Yasukatsu Yuda ,  Motohiro Nishio ,  Yuji Matsuhashi ,  Takashi Tsuruoka ,  Kiyoaki Katano ,  Shigeharu Inoye

发明人： Tomoya Machinami ,  Kazue Yasufuku ,  Seiji Shibahara ,  Fumiya Hirano ,  Yasukatsu Yuda ,  Motohiro Nishio ,  Yuji Matsuhashi ,  Takashi Tsuruoka ,  Kiyoaki Katano ,  Shigeharu Inoye

IPC分类号： C07D235/28 ,  C07D277/74 ,  A61K31/415 ,  A61K31/425 ,  C07D277/76

CPC分类号： C07D235/28 ,  C07D277/74

摘要： A novel benzothiazole or benzimidazole derivative represented by formula (I) ##STR1## wherein X represents a sulfur atom or a NH group; R.sup.1 represents a hydrogen atom, a lower alkoxy group, a chlorine atom, a bromine atom or an iodine atom; R.sup.2 represents a hydrogen atom a substituted or unsubstituted lower alkyl group, a vinyl group, an aryl group or an acyl group; m is an integer of 1, 2 or 3; and n is an integer of 0, 1 or 2, which shows an excellent acid secretion suppressing effect and gastric mucosa protecting effect, and an antiulcer agent containing the same as an active ingredient.

摘要翻译： 由式（I）表示的新型苯并噻唑或苯并咪唑衍生物其中X表示硫原子或NH基团; R1表示氢原子，低级烷氧基，氯原子，溴原子或碘原子; R2代表氢原子取代或未取代的低级烷基，乙烯基，芳基或酰基; m为1,2或3的整数; n为0或1或2的整数，表现出优异的酸分泌抑制效果和胃粘膜保护作用，以及含有作为活性成分的抗溃疡剂。

公开(公告)号：US5141946A

公开(公告)日：1992-08-25

申请号：US716622

申请日：1991-06-14

申请人： Kiyoaki Katano ,  Tamako Tomomoto ,  Hiroko Ogino ,  Naoki Yamazaki ,  Fumiya Hirano ,  Yasukatsu Yuda ,  Fukio Konno ,  Motohiro Nishio ,  Tomoya Machinami ,  Seiji Shibahara ,  Takashi Tsuruoka ,  Shigeharu Inouye

发明人： Kiyoaki Katano ,  Tamako Tomomoto ,  Hiroko Ogino ,  Naoki Yamazaki ,  Fumiya Hirano ,  Yasukatsu Yuda ,  Fukio Konno ,  Motohiro Nishio ,  Tomoya Machinami ,  Seiji Shibahara ,  Takashi Tsuruoka ,  Shigeharu Inouye

IPC分类号： C07D487/04 ,  A61K31/435 ,  A61K31/44 ,  A61K31/445 ,  A61K31/495 ,  A61K31/535 ,  A61P1/04 ,  C07D471/04 ,  C07D498/04 ,  C07D513/04

CPC分类号： C07D471/04 ,  C07D513/04

摘要： Compounds of the general formula (I): ##STR1## and pharmaceutically acceptable salts thereof, in whichA, B, C and D each represent --CH.dbd. or --N.dbd., with the proviso that at least one of them is --N.dbd.;X represents --NH--, --O-- or --S--;Y represents --(CH.sub.2).sub.p -- wherein p is an integer from 0 to 4, --C(CH.sub.3).sub.2 --, --CH.sub.2 CH.dbd.CH--, --CH.sub.2 CO--, --CF.sub.2 -- or --CH.sub.2 COCH.sub.2 --;R.sup.1 represents a hydrogen atom, a C.sub.1-4 alkyl group, a halogen atom or a C.sub.1-4 alkoxy group;R.sup.2 represnts a hydrogen atom, a hydroxyl group, a saturated or unsaturated C.sub.1-6 alkyl group, a C.sub.1-6 alkoxy group, a carboxyl group, a saturated or unsaturated C.sub.1-12 alkoxycarbonyl group which may be optionally substituted, a cycloalkoxycarbonyl group, a saturated or unsaturated five- or six-memebered heterocyclic group containing at least one nitrogen atom optionally with one or more nitrogen and/or oxygen atoms, which may be optionally condensed and/or substituted, --CONR.sup.3 R.sup.4, --NR.sup.3 R.sup.4, --OCOR.sup.3 or --NHCONHR.sup.3 wherein R.sup.3 and R.sup.4, which may be the same or different, represent a C.sub.1-6 alkyl group which may be optionally substituted or a cycloalkyl group, andm and n each represent an integrer from 0 to 2.The compounds are useful in treating ulcers.

摘要翻译： 通式（I）的化合物：其中A，B，C和D各自表示-CH =或-N =，条件是其中至少一个为 -N =; X表示-NH-，-O-或-S-; Y表示 - （CH 2）p - ，其中p是0至4的整数，-C（CH 3）2 - ， - CH 2 CH = CH - ， - CH 2 CO - ， - CF 2 - 或-CH 2 COCH 2 - R1表示氢原子，C1-4烷基，卤素原子或C1-4烷氧基; R2表示氢原子，羟基，饱和或不饱和的C1-6烷基，C1-6烷氧基，羧基，可以任意取代的饱和或不饱和的C 1-12烷氧基羰基，环烷氧基羰基， 含有至少一个氮原子的饱和或不饱和五元或六元杂环基团，任选具有一个或多个氮原子和/或氧原子，其可以任选地被缩合和/或取代，-CONR 3 R 4，-NR 3 R 4，-OCOR 3或 - NHCONHR 3其中R3和R4可以相同或不同，表示可以任选被取代的C 1-6烷基或环烷基，m和n各自表示0至2的整数。该化合物可用于处理 溃疡

公开(公告)号：US5079255A

公开(公告)日：1992-01-07

申请号：US544671

申请日：1990-06-27

申请人： Kiyoaki Katano ,  Tamako Tomomoto ,  Hiroko Ogino ,  Yamazaki Naoki ,  Fumiya Hirano ,  Yasukatsu Yuda ,  Fukio Konno ,  Motohiro Nishio ,  Tomoya Machinami ,  Seiji Shibahara ,  Takashi Tsuruoka ,  Shigeharu Inouye

发明人： Kiyoaki Katano ,  Tamako Tomomoto ,  Hiroko Ogino ,  Yamazaki Naoki ,  Fumiya Hirano ,  Yasukatsu Yuda ,  Fukio Konno ,  Motohiro Nishio ,  Tomoya Machinami ,  Seiji Shibahara ,  Takashi Tsuruoka ,  Shigeharu Inouye

IPC分类号： C07D487/04 ,  A61K31/435 ,  A61K31/44 ,  A61K31/445 ,  A61K31/495 ,  A61K31/535 ,  A61P1/04 ,  C07D471/04 ,  C07D498/04 ,  C07D513/04

CPC分类号： C07D471/04 ,  C07D513/04

摘要： Compounds of the general formula (I): ##STR1## and pharmaceutically acceptable salts thereof, in which A, B, C and D each represent --CH.dbd. or --N.dbd., with the proviso that at least one of them is --N.dbd.;X represents --NH--, --O-- or --S--;Y represents --(CH.sub.2).sub.p -- wherein p is an integer from 0 to 4, --C(CH.sub.3).sub.2 --, --CH.sub.2 CH.dbd.CH--, --CH.sub.2 CO--, --CF.sub.2 -- or --CH.sub.2 COCH.sub.2 --;R.sup.1 represents a hydrogen atom, a C.sub.1-4 alkyl group, a halogen atom or a C.sub.1-4 alkoxy group;R.sup.2 represents a hydrogen atom, a hydroxyl group, a saturated or unsaturated C.sub.1-6 alkyl group, a C.sub.1-6 alkoxy group, a carboxyl group, a saturated or unsaturated C.sub.1-12 alkoxycarbonyl group which may be optionally substituted, a cycloalkoxycarbonyl group, a saturated or unsaturated five- or six-membered heterocyclic group containing at least one nitrogen atom optionally with one or more nitrogen and/or oxygen atoms, which may be optionally condensed and/or substituted, --CONR.sup.3 R.sup.4, --NR.sup.3 R.sup.4, --OCOR.sup.3 or --NHCONHR.sup.3 wherein R.sup.3 and R.sup.4, which may be the same or different, represent a C.sub.1-6 alkyl group which may be optionally substituted or a cycloalkyl group, andm and n each represent an integer from 0 to 2.

公开(公告)号：US5200407A

公开(公告)日：1993-04-06

申请号：US716621

申请日：1991-06-14

申请人： Kiyoaki Katano ,  Tamako Tomomoto ,  Hiroko Ogino ,  Naoki Yamazaki ,  Fumiya Hirano ,  Yasukatsu Yuda ,  Fukio Konno ,  Motohiro Nishio ,  Tomoya Machinami ,  Seiji Shibahara ,  Takashi Tsuruoka ,  Shigeharu Inouye

发明人： Kiyoaki Katano ,  Tamako Tomomoto ,  Hiroko Ogino ,  Naoki Yamazaki ,  Fumiya Hirano ,  Yasukatsu Yuda ,  Fukio Konno ,  Motohiro Nishio ,  Tomoya Machinami ,  Seiji Shibahara ,  Takashi Tsuruoka ,  Shigeharu Inouye

IPC分类号： C07D471/04 ,  C07D498/04 ,  C07D513/04

CPC分类号： C07D471/04 ,  C07D513/04

摘要： Compounds of the general formula (I): ##STR1## and pharmaceutically acceptable salts thereof, in which A, B, C and D each represent --CH.dbd. or --N.dbd., with the proviso that at least one of them is --N.dbd.;X represents --NH--, --O-- or --S--;Y represents --(CH.sub.2).sub.p -- wherein p is an integer from 0 to 4, --C(CH.sub.3).sub.2 --, --CH.sub.2 CH.dbd.CH--, --CH.sub.2 CO--, --CF.sub.2 -- or --CH.sub.2 COCH.sub.2 --;R.sup.1 represents a hydrogen atom, a C.sub.1-4 alkyl group, a halogen atom or a C.sub.1-4 alkoxy group;R.sup.2 represents a hydrogen atom, a hydroxyl group, a saturated or unsaturated C.sub.1-6 alkyl group, a C.sub.1-6 alkoxy group, a carboxyl group, a saturated or unsaturated C.sub.1-12 alkoxycarbonyl group which may be optionally substituted, a cycloalkoxycarbonyl group, a saturated or unsaturated five- or six-membered heterocyclic group containing at least one nitrogen atom optionally with one or more nitrogen and/or oxygen atoms, which may be optionally condensed and/or substituted, --CONR.sup.3 R.sup.4, --NR.sup.3 R.sup.4, --OCOR.sup.3 or --NHCONHR.sup.3 wherein R.sup.3 and R.sup.4, which may be the same or different, represent a C.sub.1-6 alkyl group which may be optionally substituted or a cycloalkyl group, andm and n each represent an integer from 0 to 2.

摘要翻译： 通式（I）的化合物：其中A，B，C和D各自表示-CH =或-N =，条件是其中至少一个为 -N =; X表示-NH-，-O-或-S-; Y表示 - （CH 2）p - ，其中p是0至4的整数，-C（CH 3）2 - ， - CH 2 CH = CH - ， - CH 2 CO - ， - CF 2 - 或-CH 2 COCH 2 - R1表示氢原子，C1-4烷基，卤素原子或C1-4烷氧基; R2表示氢原子，羟基，饱和或不饱和的C1-6烷基，C1-6烷氧基，羧基，可以任意取代的饱和或不饱和的C 1-12烷氧基羰基，环烷氧基羰基， 含有至少一个氮原子的饱和或不饱和五元或六元杂环基，任选具有一个或多个氮和/或氧原子，其可以任选地被缩合和/或取代，-CONR 3 R 4，-NR 3 R 4，-OCOR 3或 - NHCONHR 3其中R3和R4可以相同或不同，表示可以被任意取代的C 1-6烷基或环烷基，m和n各自表示0〜2的整数。